摘要
背景:老年人的认知减退与神经类固醇激素维生素D的不足相关。认知减退的主观认知影响还未能被检测到。这项基于医院的横断面研究为了确定老年病人的主观认知疾病是否与维生素D不足有关。方法:在“认知和亲脂性维生素”(CLIP)研究中99位连贯的白种人和招募病人没有出现晚期认知紊乱(简易精神状态检得分≥20),维生素D摄入不足者依据维生素D量的不足分为2组(血清25-羟基维生素D≥75nmol/L)。采用记忆抱怨调查问卷(MAC-Q;得分0-30;最好)检测主观认知障碍。MAQ-Q得分小于15或者大于30定于为重度认知障碍。年龄、性别、体质指数、教育水平、共患病负荷、功能自主、情绪、血浆甲状旁腺素浓度、钙、促甲状腺素和维生素12及估算肾小球滤过率被作为潜在的混杂因素。结果:与那些血浆25OHD>75nmol/L 的参与者相比,那些维生素D不足者(n=89)的MAC-Q平均得分较低(14.9±2.9与 17.1±1.6, P=0.02),并且MAQ得分小于15的可能性更大(52.8% 与10.0%, P=0.01)。维生素D不足与MAC-Q得分呈负相关(调整β=-2.84, P=0.03),并且与重度认知障碍呈正相关(调整 OR=10.07, P=0.03)结论:在老年病人研究组中,维生素D不足与主观认知障碍相关。
关键词: 认知,认知障碍,痴呆,神经内分泌学,老年人,维生素D
Current Alzheimer Research
Title:Biology of Subjective Cognitive Complaint Amongst Geriatric Patients: Vitamin D Involvement
Volume: 12 Issue: 2
Author(s): Elena De Neree Tot Babberich, Clemence Gourdeau, Simon Pointel, Bruno Lemarchant, Olivier Beauchet and Cedric Annweiler
Affiliation:
关键词: 认知,认知障碍,痴呆,神经内分泌学,老年人,维生素D
摘要: Background: Insufficiency in vitamin D, a neurosteroid hormone, is associated with cognitive decline in older adults. The impact on the subjective perception of cognitive decline has not yet been examined. The objective of this cross-sectional hospital-based study was to determine whether vitamin D insufficiency was associated with subjective cognitive complaint amongst geriatric patients. Methods: Ninety-nine consecutive Caucasian in- and outpatients recruited in the ’Cognition and LIPophilic vitamins’ (CLIP) study, who had no advanced cognitive disorders (ie, Mini-Mental State Examination score≥20) and who took no vitamin D supplements, were categorized into 2 groups based on vitamin D insufficiency (ie, serum 25-hydroxyvitamin D≥75nmol/L). Subjective cognitive complaint was examined using the Memory Complaint Questionnaire (MAC-Q; score 0-30, best). MAC-Q score<15 out of 30 defined severe cognitive complaint. Age, gender, body mass index, education level, comorbidity burden, functional autonomy, mood, and serum concentrations of parathyroid hormone, calcium, thyroid-stimulating hormone and vitamin B12, and estimated glomerular filtration rate were used as potential confounders. Results: Compared to participants with serum 25OHD>75nmol/L, those with vitamin D insufficiency (n=89) had a lower mean MAC-Q score (14.9±2.9 versus 17.1±1.6, P=0.02) and more often a MAC-Q score<15 (52.8% versus 10.0%, P=0.01). Vitamin D insufficiency was inversely associated with the MAC-Q score (adjusted β=-2.84, P=0.03), and positively associated with severe cognitive complaint (adjusted OR=10.07, P=0.03). Conclusion: Vitamin D insufficiency was associated with subjective cognitive complaint in the studied cohort of geriatric patients.
Export Options
About this article
Cite this article as:
Elena De Neree Tot Babberich, Clemence Gourdeau, Simon Pointel, Bruno Lemarchant, Olivier Beauchet and Cedric Annweiler , Biology of Subjective Cognitive Complaint Amongst Geriatric Patients: Vitamin D Involvement, Current Alzheimer Research 2015; 12 (2) . https://dx.doi.org/10.2174/1567205012666150204123504
DOI https://dx.doi.org/10.2174/1567205012666150204123504 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cognitive, Psychological and Psychiatric Effects of Ionizing Radiation Exposure
Current Medicinal Chemistry Acute Phase Proteins In Acute Coronary Syndrome: An up-to-date
Cardiovascular & Hematological Agents in Medicinal Chemistry Natural Compounds Used as Therapies Targeting to Amyotrophic Lateral Sclerosis
Current Pharmaceutical Biotechnology Smoking and Hypertension: Effects on Clinical, Biochemical and Pathological Variables Due to Isolated or Combined Action on Cardiovascular System
Current Pharmaceutical Design PET Radiotracers for Molecular Imaging in Dementia
Current Radiopharmaceuticals Management of Dyslipidaemia for the Prevention of Stroke: Clinical Practice Recommendations from the Lipid Association of India
Current Vascular Pharmacology Adrenergic Drugs Blockers or Enhancers for Cognitive Decline ? What to Choose for Alzheimer’s Disease Patients?
CNS & Neurological Disorders - Drug Targets An Overview of Innovations in Analysis and Beneficial Health Effects of Wine Polyphenols
Mini-Reviews in Medicinal Chemistry Applications of Artificial Neural Networks in Medical Science
Current Clinical Pharmacology Neurotrophic Factors in the Pathogenesis of Neurological Disorders with Mental Retardation in Children
Current Pediatric Reviews The Inverse Relationship Between Cancer and Alzheimer's Disease: A Possible Mechanism
Current Alzheimer Research Pleiotropic Effects of the Rho-kinase Inhibitor Fasudil After Subarachnoid Hemorrhage: A Review of Preclinical and Clinical Studies
Current Vascular Pharmacology FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus
Current Neurovascular Research Chitinases: Biomarkers for Human Diseases
Protein & Peptide Letters Effects of Atorvastatin on Cerebral Blood Flow in Middle-Aged Adults at Risk for Alzheimer’s Disease: A Pilot Study
Current Alzheimer Research Stroke and Neuroinflamation: Role of Sexual Hormones
Current Pharmaceutical Design Effects of SORL1 Gene on Alzheimer's Disease. Focus on Gender, Neuropsychiatric Symptoms and Pro-Inflammatory Cytokines
Current Alzheimer Research AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal Models
Current Alzheimer Research Interaction of Buffalo Brain Cystatin with Serotonin
Current Nanoscience Editorial (Thematic Issue: New Therapeutic Targets in Clinical Medicine)
Current Pharmaceutical Design